What Is a Robertsonian Translocation?

A Robertsonian translocation is a chromosomal rearrangement in which two chromosomes fuse together at their central hubs, producing one combined chromosome where there used to be two separate ones. Carriers walk around with 45 chromosomes instead of the usual 46, yet almost always appear completely healthy, because no critical genetic material is actually lost in the swap. The translocation becomes medically significant during reproduction, when the fused chromosome can sort unevenly into eggs or sperm and raise the risk of miscarriage or a child with a chromosomal condition like Down syndrome or Patau syndrome. About one in every thousand people carries one, making it the single most common structural chromosome rearrangement in humans.

Which Chromosomes Are Involved

Human chromosomes come in several shapes. Most have their centromere (the pinch point that holds the two halves together) somewhere near the middle. Five chromosomes, numbered 13, 14, 15, 21, and 22, are different: their centromeres sit very close to one end, leaving a long arm packed with essential genes and a stubby short arm that mostly carries repetitive DNA and ribosomal RNA gene clusters. These five are called acrocentric chromosomes, and they are the only ones eligible for a Robertsonian translocation.

During the rearrangement, the long arms of two acrocentric chromosomes join together while the short arms are lost. Because those short arms contain ribosomal DNA sequences that also exist on other acrocentric chromosomes, the body has backup copies and does not miss them. That is why a balanced carrier, someone who has the fused chromosome but no net gain or loss of important genes, is typically healthy with no outward signs beyond the chromosome count on a karyotype report.

Not all combinations occur equally. The fusion of chromosomes 13 and 14, written rob(13;14), is the most frequent by a wide margin. The 14;21 fusion comes second. Rarer pairings like rob(15;22) account for a tiny fraction, less than one percent of all Robertsonian translocations reported.

How It Forms

The majority of new (de novo) Robertsonian translocations arise during the formation of the mother’s egg cells. In a study of 29 de novo cases combined with 35 previously published cases, the common types such as rob(13;14) and rob(14;21) originated during oogenesis in the vast majority of instances.

Researchers have proposed a model to explain why these fusions happen in the first place. The ribosomal DNA arrays on acrocentric chromosomes tend to cluster together inside the same structure in the cell nucleus, called the nucleolus. That physical closeness brings the short arms of different acrocentric chromosomes near one another. A DNA break can then occur within repetitive sequences near the centromere, and the repair process occasionally joins the long arms of two different chromosomes instead of patching each one back to its own short arm. Most DNA breaks during egg or sperm formation resolve harmlessly, but a rare crossover event between chromosomes 14 and 13 (or 14 and 21) can fuse their long arms and, reciprocally, join the short arms into a tiny fragment that is eventually lost.

Common Robertsonian translocations tend to share the same breakpoints and likely form through one consistent mechanism, while rarer types seem to arise through more varied or random processes.

How Carriers Pass It On

The real clinical significance of a Robertsonian translocation emerges at reproduction. During the cell division that produces eggs or sperm, chromosomes must pair up and separate evenly. A fused chromosome has to line up against its two free counterparts, creating a group of three rather than the usual pair. How those three chromosomes sort into daughter cells determines whether the resulting egg or sperm is chromosomally balanced or not.

There are several possible outcomes when the group of three separates:

  • Alternate segregation: The fused chromosome goes to one cell while the two free chromosomes go to the other. Both cells end up with a complete set of genes, either carrying the translocation (balanced) or having a normal karyotype. This is the favorable outcome.
  • Adjacent segregation: The fused chromosome travels with one of the free chromosomes, so one cell gets too much genetic material and the other gets too little. These unbalanced combinations usually cause miscarriage or, less often, a live-born child with a trisomy.
  • 3:0 segregation: All three go to the same cell. This is rare and almost always lethal to the embryo.

Studies that analyze sperm from male carriers consistently find that alternate segregation dominates. In one analysis of multiple carriers, the proportion of sperm with a normal or balanced chromosome set ranged from about 68 to 94 percent, with an average near 79 percent. Adjacent segregation accounted for roughly 18 percent on average, and 3:0 segregation hovered around 2 to 3 percent. Still, somewhere between 6 and 32 percent of a carrier’s sperm may be unbalanced, which is the biological basis for the increased reproductive risk. A separate study of a single rob(14;21) carrier found 88 percent of sperm were balanced, with just over 11 percent from adjacent segregation. Sperm carrying an extra copy of chromosome 21 (the kind that could lead to translocation Down syndrome) accounted for about 2.5 percent, a figure consistent with the observed rates of unbalanced offspring at birth.

Miscarriage and Pregnancy Outcomes

Carriers of Robertsonian translocations face a higher-than-average rate of miscarriage. In a detailed study of 101 families carrying a rob(13;14), female carriers had a miscarriage rate of roughly 28 percent of spontaneous pregnancies, which is above the background rate. The same study found that earlier estimates may have underestimated miscarriage frequency because some researchers excluded losses that had not been karyotyped. Stillbirth rates were about 3 percent for female carriers and lower, around 1.4 percent, for male carriers.

There is a pattern in how the translocation is discovered. Carriers identified because they experienced infertility or repeated miscarriages tend to have worse reproductive outcomes than carriers identified incidentally, say because a relative was tested. That difference likely reflects ascertainment bias rather than a biological difference between the two groups: families with the worst luck are the ones who come to medical attention first. Regardless of the reason for testing, prenatal chromosome analysis is recommended in pregnancies where a parent carries a Robertsonian translocation.

Translocation Down Syndrome

Most cases of Down syndrome result from a straightforward extra copy of chromosome 21, giving a total of 47 chromosomes. But about 3 to 4 percent of people with Down syndrome have a translocation form, in which the extra chromosome 21 material is attached to another chromosome, often chromosome 14. The child has 46 chromosomes on a count, but one of them is the fused rob(14;21) carrying the extra long arm of chromosome 21.

For female carriers of a rob(14;21), the empirical risk of having a live-born child with translocation trisomy 21 is estimated at about 10 percent. Male carriers have a substantially lower risk, around 1 to 2 percent, likely because unbalanced sperm are less viable or are selected against during fertilization. These figures are far lower than the one-in-three theoretical probability that random chromosome segregation would predict, but they are still high enough to warrant genetic counseling and prenatal testing.

There is also a special situation with homologous Robertsonian translocations, where both long arms come from the same chromosome. A carrier of rob(21;21), for instance, cannot produce a balanced gamete that lacks an extra dose of chromosome 21. Every pregnancy from that carrier will result in either trisomy 21 or monosomy 21 (which does not survive). This makes the recurrence risk effectively 100 percent for Down syndrome, a scenario that calls for very different counseling than the nonhomologous types.

Patau Syndrome and Chromosome 13

Chromosome 13 is another acrocentric chromosome commonly involved in Robertsonian translocations. Trisomy 13, known as Patau syndrome, is much rarer than trisomy 21, occurring in roughly 1 in 12,000 live births. A portion of those cases arise from Robertsonian translocations rather than simple trisomy. Pooled data from over 167,000 live births found that translocation-based Patau syndrome occurred in about 1 in 24,000 births, split between new mutations and inherited translocations.

In the rob(13;14) family study mentioned earlier, translocation trisomy 13 was diagnosed in about 7 percent of amniocenteses performed on carrier mothers. Despite that prenatal detection rate, no live-born children with Patau syndrome were found in the ascertainment-corrected sample, suggesting that most of these pregnancies end in miscarriage or stillbirth rather than a live delivery. The confirmed low risk of a live-born child with trisomy 13 from rob(13;14) carriers is somewhat reassuring, but the elevated miscarriage rate remains the practical burden for these families.

The Uniparental Disomy Wrinkle

There is a subtler genetic risk that sometimes catches families off guard. When an embryo starts out with a trisomy (three copies of a chromosome) and the body “rescues” itself by discarding the extra copy, it occasionally ends up with both remaining copies from the same parent. This is called uniparental disomy, or UPD. For most chromosomes, having both copies from one parent does not matter, but chromosomes 14 and 15 contain imprinted genes, meaning the body expects one copy to come from mom and one from dad. When both come from the same parent, certain genes are silenced or overexpressed in ways that cause distinct clinical syndromes.

UPD of chromosome 15 from the mother causes Angelman syndrome; UPD of chromosome 15 from the father causes Prader-Willi syndrome. UPD of chromosome 14 produces its own set of growth and developmental problems depending on which parent contributed both copies. Because Robertsonian translocations involving chromosomes 14 or 15 raise the baseline chance of trisomy and subsequent rescue, UPD testing has traditionally been recommended when a fetus is found to carry a balanced translocation involving these chromosomes.

That said, the actual risk turns out to be very low. An older estimate put the chance at roughly 0.6 to 0.8 percent. A more recent evaluation of nearly 1,750 UPD tests in fetuses with an inherited Robertsonian translocation found only one positive case, yielding a revised estimate of about 0.06 percent. The researchers pointed out that the risk of miscarriage from the invasive sampling procedure itself may be higher than the UPD risk, and they argued against routine invasive UPD testing for these pregnancies. This remains a judgment call for individual families and their genetic counselors, but the data suggest the older estimates were overly alarming.

Preimplantation Genetic Testing

For couples who know they carry a Robertsonian translocation and want to avoid transferring an unbalanced embryo, preimplantation genetic testing for structural rearrangements (PGT-SR) during IVF has become the standard approach. The technology has evolved considerably. Early attempts in the late 1990s used a technique called FISH on polar bodies from eggs, but this had a failed diagnosis rate as high as 24 percent and could not detect paternal translocations at all. Cleavage-stage biopsy with FISH followed, but it too had problems: one reanalysis of 50 embryos previously called abnormal by FISH found that 58 percent of them were actually chromosomally normal on more advanced testing.

Modern PGT-SR uses comprehensive chromosome screening on cells biopsied from blastocyst-stage embryos, typically with next-generation sequencing. This approach examines all 24 chromosome types at once, catching not only imbalances from the translocation but also unrelated chromosome errors that FISH would have missed entirely.

Robertsonian translocation carriers have a meaningful advantage in PGT-SR compared to carriers of reciprocal translocations. Embryos from Robertsonian carriers had significantly higher odds of being transferable, roughly 2.7 times the odds compared to reciprocal translocation carriers, regardless of the mother’s age. Once a normal or balanced embryo is transferred, pregnancy and live birth rates are similar between the two types. Interestingly, one study found that female Robertsonian carriers produce a higher proportion of chromosomally abnormal embryos than male carriers, consistent with the sperm data showing that male carriers produce mostly balanced gametes. Despite this difference in embryo quality, the pregnancy and live birth rates after transferring a screened embryo were not affected by whether the mother or father carried the translocation.

Why Carriers Appear Healthy

A balanced Robertsonian translocation carrier has all the genetic information they need for normal development; it is just packaged in 45 pieces instead of 46. The lost short-arm material is redundant with ribosomal DNA on the remaining acrocentric chromosomes. Large studies of translocation carriers confirm that they have no abnormal physical features beyond fertility-related problems in some cases.

One occasionally raised concern is whether having fewer ribosomal RNA gene copies could subtly affect health. Ribosomal RNA is critical for building the cell’s protein-making machinery, and each acrocentric short arm carries clusters of these genes. Losing two short arms reduces the total ribosomal gene count, but the remaining copies on other chromosomes appear to compensate. There is no consistent evidence that balanced carriers have impaired growth, immune function, or cellular performance as a result of reduced ribosomal gene dosage. The clinical literature is remarkably clear: balanced carriers live normal lives, and the translocation is usually discovered only because of a reproductive event or incidental karyotyping.

Robertsonian Translocations in Other Species

Humans are not the only mammals where these fusions matter. In livestock, the rob(1;29) translocation in cattle is one of the most studied chromosomal abnormalities in agriculture. A 30-year retrospective study of beef cattle found that heterozygous cows carrying the translocation had a significant decrease in reproductive efficiency of about 5 percent. By contrast, homozygous carriers and non-carriers showed no decrease. The practical solution has been straightforward: selecting against carrier bulls over three decades reduced the translocation’s frequency in the herd to negligible levels.

The house mouse has become a particularly rich model for understanding how Robertsonian translocations drive evolutionary change. Wild populations of the western European house mouse carry an extraordinary variety of Robertsonian fusions, and different populations have accumulated different combinations, effectively creating “chromosomal races.” When two populations with different fusions meet and interbreed, their hybrid offspring have multiple mismatched chromosomes that pair poorly during meiosis, reducing fertility. Over time, this reproductive barrier can contribute to the formation of new species. In mammals more broadly, Robertsonian translocation is considered the most effective chromosomal process leading to speciation.

Human Chromosome 2 and an Ancient Fusion

One of the most striking pieces of evidence for human evolution involves a Robertsonian-type event in our own lineage. Great apes have 48 chromosomes; humans have 46. The difference is explained by the fusion of two ancestral ape chromosomes into what we now call human chromosome 2. Molecular analysis revealed that sequences which once sat at the tips (telomeres) of the two ancestral chromosomes are now buried in the middle of chromosome 2, at the band 2q13-2q14.1 region, marking the exact point where the two chromosomes joined head to head.

This ancient fusion was not a Robertsonian translocation in the strict sense, because it involved telomere-to-telomere joining rather than centromere-region fusion of acrocentric chromosomes. But it belongs to the same broad family of whole-arm chromosome fusions that reshape mammalian genomes over evolutionary time. The event likely occurred in a single individual who then carried 47 chromosomes, produced offspring with either 47 or 46, and eventually the 46-chromosome version became fixed in the human lineage. The persistence of the interstitial telomere sequences after millions of years is a molecular fossil of that founding rearrangement.

Rare and Homologous Types

While rob(13;14) and rob(14;21) make up the vast majority of cases, unusual pairings do occur. A rob(15;22), for example, accounts for only about 0.6 percent of all reported Robertsonian translocations. A case from India described a mother who carried a balanced rob(15;22) and whose son had trisomy 21 as a separate, unrelated event on top of the translocation, illustrating that carriers can still experience ordinary chromosomal non-disjunction independent of the translocation itself.

Homologous Robertsonian translocations, where both long arms derive from the same chromosome pair, present a unique counseling challenge. A carrier of rob(21;21) or rob(22;22) has no way to produce a gamete with a normal or merely balanced set. Every viable pregnancy will receive either two copies or zero copies of the involved chromosome’s long arm. For rob(21;21), that means every surviving pregnancy results in Down syndrome. For rob(22;22), the situation is similar but with trisomy 22 or monosomy 22, both usually lethal. One reported case of a woman with rob(22;22) experienced recurrent pregnancy loss, consistent with the expectation that no viable outcome is possible without assisted reproduction using donor eggs or preimplantation testing with specialized strategies. These homologous rearrangements are, fortunately, exceedingly rare, and the vast majority of carriers encountered in clinical practice have the nonhomologous type, where alternate segregation can and usually does produce healthy offspring.